statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Buy Dr Lal Pathlabs; target of Rs 2800: Emkay

Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 2800 in its research report dated May 10, 2024.

Govt should give incentives to healthcare sector similar to chip industry: Dr Lal PathLabs' Arvind Lal

Lal said that the private sector can collaborate with the government in providing services where the state-run hospitals are found to be lacking

Dr Lal PathLabs' strong Q4 results, upbeat commentary paints a comeback picture; stock up 8%

According to analysts, the biggest positive from Dr Lal PathLabs' commentary is their guidance to achieve double-digit revenue growth in FY25 without price hikes.

Dr. Lal PathLabs Q4 profit rises 52% to Rs 85 crore, revenue up 11%

The company also recommended a final dividend of Rs 6 per equity share (@ 60% on a face value of Rs 10 each) for the financial year ended March 31, 2024.

Top 10 stock ideas for May series when D-St bulls charge Nifty towards 22,800

As long as the Nifty 50 holds 22,300-22,200 levels on closing basis, the upward march towards 22,800 can't be ruled out in the coming sessions.

Hot stocks: Bet on Dr Lal PathLabs, Bharat Dynamics, DLF for short term

DLF stock is demonstrating a bullish trend, consistently forming higher highs and higher lows.

Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. It also involves in providing diagnostic and healthcare tests and services. The company was founded by S. K. Lal in 1949 and is headquartered in Gurgaon, India.

Volume	80,715.00
52-Wk High	3,095.00
52-Wk Low	1,943.70

LALPATHLAB.NSE Dr. Lal PathLabs Ltd.

About

Feed

News

Sentiment

Fundamentals